Amneal launches generic form of Tamiflu
BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched oseltamivir phosphate capsules, USP, in three strengths: 30-mg, 45-mg and 75-mg. The Amneal generic is an AB-rated therapeutic equivalent to Tamiflu. Each strength is available in 10-count blister dose-packs.
“Flu season is closer than we realize,” said Jim Luce, Amneal EVP, sales and marketing. “Amneal strives to assist healthcare providers and their patients by providing more affordable and greater access to treatment with our generic medication.”
Manufactured in the recently expanded Amneal facility in Brookhaven, N.Y., oseltamivir capsules began shipping July 11 from the company’s Glasgow, Ky., distribution center and can be purchased through major wholesalers and distributors. Annual U.S. sales of Tamiflu were $444 million according to May 2017 QuintilesIMS market data.